NCT05630950Active, not recruiting
LDCT-SC-FI Low-dose CT Screening for Lung Cancer
Low-dose CT Screening for Lung Cancer Combined to Different Smoking Cessation Methods in Finland
Source: ClinicalTrials.gov · Last updated 24 Aug 2025
Brief summary (registry, in English)
This is a randomized phase II trial investigating different smoking cessation methods in study subjects undergoing lung cancer screening with low-dose CT (LDCT). The study also evaluates feasibility and outcomes of LDCT screening and potential biomarkers and AI-based evaluation on CT-scans. The study subjects fulfilling I/E-criteria are randomized in 1:1 fashion to yearly LDCT for two rounds with standard smoking cessation (control) or same LDCT approach combined to mobile application based smoking cessation (intervention).
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 18 Nov 2022
- Start date
- 18 Nov 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Oulu University Hospital
- Diseases
- Lung cancer
- NCT number
- NCT05630950
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 18 Nov 2022 to the primary completion date, 31 Dec 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Current or past melanoma, lung, renal or breast cancer
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- Any condition that study investigators consider an impediment to safe trial participation
Other
- A moderate or bad self-reported health; e.g. unable to climb two flights of stairs
- Body weight ≥ 140 kilogram
- A chest CT examination less than one year before inclusion
- Subject is unwilling or unable to comply with treatment and trial instructions
Who the study is looking for
- Able to provide written informed consent
- Age between 50-74
- Smoked ≥ 15 cigarettes/day for ≥ 25 years or smoked ≥ 10 cigarettes/day for ≥ 30 years and are active smokers (smoking during the last two weeks)
- Access to a smartphone (iPhone or Android)
Age in the registry: 50 years to 74 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oulu University Hospital Coordinator of this site? Confirm its status | Oulu | Finland | Unknown status |
| Vaasa Central Hospital Coordinator of this site? Confirm its status | Vaasa | Finland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.